tradingkey.logo

Shoulder Innovations Inc

SI
查看詳細走勢圖
15.550USD
+0.230+1.50%
收盤 12/22, 16:00美東報價延遲15分鐘
320.09M總市值
虧損本益比TTM

Shoulder Innovations Inc

15.550
+0.230+1.50%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.50%

5天

+7.61%

1月

+5.85%

6月

0.00%

今年開始到現在

0.00%

1年

0.00%

查看詳細走勢圖

TradingKey Shoulder Innovations Inc股票評分

單位: USD 更新時間: 2025-12-22

操作建議

Shoulder Innovations Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名142/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價20.60。中期看,股價處於上升通道。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Shoulder Innovations Inc評分

相關信息

行業排名
142 / 208
全市場排名
417 / 4578
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 5 分析師
買入
評級
20.600
目標均價
+39.38%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Shoulder Innovations Inc亮點

亮點風險
Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The Company offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.
業績增長期
公司處於發展階段,最新年度總收入31.62M美元
估值低估
公司最新PE估值-2.18,處於3年歷史低位
機構加倉
最新機構持股12.77M股,環比增加42.48%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉146.27K股

Shoulder Innovations Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Shoulder Innovations Inc簡介

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The Company offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.
公司代碼SI
公司Shoulder Innovations Inc
CEOBall (Robert Joseph)
網址https://shoulderinnovations.com/

常見問題

Shoulder Innovations Inc(SI)的當前股價是多少?

Shoulder Innovations Inc(SI)的當前股價是 15.550。

Shoulder Innovations Inc 的股票代碼是什麼?

Shoulder Innovations Inc的股票代碼是SI。

Shoulder Innovations Inc股票的52週最高點是多少?

Shoulder Innovations Inc股票的52週最高點是17.940。

Shoulder Innovations Inc股票的52週最低點是多少?

Shoulder Innovations Inc股票的52週最低點是10.920。

Shoulder Innovations Inc的市值是多少?

Shoulder Innovations Inc的市值是320.09M。

Shoulder Innovations Inc的淨利潤是多少?

Shoulder Innovations Inc的淨利潤為-13.69M。

現在Shoulder Innovations Inc(SI)的股票是買入、持有還是賣出?

根據分析師評級,Shoulder Innovations Inc(SI)的總體評級為買入,目標價格為20.600。

Shoulder Innovations Inc(SI)股票的每股收益(EPS TTM)是多少

Shoulder Innovations Inc(SI)股票的每股收益(EPS TTM)是-7.096。
KeyAI